Public-registry site landscape for NCT07742852, a Osteoarthritis (OA) of the Knee study sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07742852 (registry record) |
| Sponsor | Jiangsu Aosaikang Pharmaceutical Co., Ltd. |
| Condition(s) | Osteoarthritis (OA) of the Knee; Pain |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | China |
At Beijing Hospital — one of the facilities listed on this trial — 2 other studies are actively recruiting Osteoarthritis (OA) of the Knee patients at the same facility (public registry, as of August 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07742852 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →